Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Atropine recalled?

Yes — there is an active recall. 13 ongoing FDA recalls mention Atropine (125 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Atropine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Atropine recalls on record

none so far in 2026; 125 on record, newest first
Class II · Moderate risk

Formula 1

Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.

Terminated Stability / shelf life Meditech Laboratories, Inc D-0805-2016
Class II · Moderate risk

Formula 9

Lack of Assurance of Sterility: incomplete or missing data regarding production.

Terminated Sterility / contamination Meditech Laboratories, Inc D-0804-2016
Class III · Low risk

Donnatal

Labeling: Not elsewhere classified - Product label incorrectly lists Scopolamine Hydrocodone as an active ingredient on the side panel instead of Scopolamine Hydrobromide.

Terminated Labeling / mix-up Rx PAK NDC 59212-425-10 D-0053-2016
Class II · Moderate risk

atropine Sulfate Injection

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0026-2017
Class II · Moderate risk

atropine Sulfate Injection

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0025-2017